$SHPH Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
https://www.globenewswire.com/news-release/20...stoma.html
https://www.globenewswire.com/news-release/20...stoma.html